Suppr超能文献

中重度下尿路症状患者代谢综合征与临床良性前列腺增生进展预测因素及国际前列腺症状评分之间的关系

Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.

作者信息

Zhao Sicong, Chen Chao, Chen Zongping, Xia Ming, Tang Jianchun, Shao Sujun, Yan Yong

机构信息

Department of Urology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.

Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.

出版信息

Urol J. 2016 Jun 28;13(3):2717-26.

Abstract

PURPOSE

To investigate the association between metabolic syndrome (MetS) and the predictors of the progression of benign prostatic hyperplasia (BPH) and the corresponding frequency and severity of lower urinary tract symptoms (LUTS).

MATERIALS AND METHODS

A total of 530 men with moderate to severe International Prostate Symptom Score (IPSS) > 7 were recruited in the present study. The predictors for clinical BPH progression were defined as the total prostate volume (TPV) ≥ 31 cm3, prostate-specific antigen level (PSA) ≥ 1.6 ng/mL, maximal flow rate (Qmax) < 10.6 mL/s, postvoid residual urine volume (PVR) of ≥ 39 mL, and age 62 years or older. LUTS were defined according to the IPSS and MetS with the National Cholesterol Education Program-Adult Treatment Panel III guidelines. The Mantel-Haenszel extension test and the multivariate logistic regression analyses were used to statistically examine their relationships.

RESULTS

The percentage of subjects with ≥ 1 predictors for clinical BPH progression, the percentage of subjects with a TPV ≥ 31 cm3, the percentage of subjects with a PVR ≥ 39 mL, and the percentage of subjects with a Qmax < 10.6 mL/s increased significantly with the increasing in the number of MetS components (all P < .05). After adjusting for age and serum testosterone level, the MetS were independently associated with the presence of TPV ≥ 31 cm3 (OR = 17.030, 95% CI: 7.495-38.692). Moreover, MetS was positively associated with the severity of LUTS (P < .001) and voiding scores (P < .001), and each individual MetS component appeared as an independent risk factor for severe LUTS (IPSS > 19, all P < .001).

CONCLUSION

Our data have shown that the MetS significantly associated with the predictors for clinical BPH progression and the frequency and severity of LUTS, especially the voiding symptoms. The prevention of such modifiable factors by promotion of dietary changes and regular physical activity practice may be of great importance for public health.&nbsp.

摘要

目的

探讨代谢综合征(MetS)与良性前列腺增生(BPH)进展的预测因素以及下尿路症状(LUTS)相应频率和严重程度之间的关联。

材料与方法

本研究共纳入530名国际前列腺症状评分(IPSS)>7的中重度男性患者。临床BPH进展的预测因素定义为前列腺总体积(TPV)≥31 cm³、前列腺特异性抗原水平(PSA)≥1.6 ng/mL、最大尿流率(Qmax)<10.6 mL/s、残余尿量(PVR)≥39 mL以及年龄62岁及以上。LUTS根据IPSS和符合美国国家胆固醇教育计划成人治疗小组第三次报告指南的MetS进行定义。采用Mantel-Haenszel扩展检验和多因素逻辑回归分析对它们之间的关系进行统计学检验。

结果

随着MetS组分数量的增加,具有≥1个临床BPH进展预测因素的受试者百分比、TPV≥31 cm³的受试者百分比、PVR≥39 mL的受试者百分比以及Qmax<10.6 mL/s的受试者百分比均显著增加(所有P<.05)。在调整年龄和血清睾酮水平后,MetS与TPV≥31 cm³独立相关(OR = 17.030,95%CI:7.495-38.692)。此外,MetS与LUTS的严重程度(P<.001)和排尿评分(P<.001)呈正相关,并且每个单独的MetS组分均表现为严重LUTS(IPSS>19)的独立危险因素(所有P<.001)。

结论

我们的数据表明,MetS与临床BPH进展的预测因素以及LUTS的频率和严重程度显著相关,尤其是排尿症状。通过促进饮食改变和定期进行体育锻炼来预防这些可改变因素可能对公众健康非常重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验